Brand Less Than Generic Program

About

The Brand Less than Generic Program is a cost containment initiative which promotes the use of certain multi-source brand name drugs
when the cost of the brand name drug is less expensive than the generic equivalent. Generic drugs included in this program require prior
authorization. Once it is determined that the generic drug is more cost-effective than the brand name equivalent, the prior authorization
requirement will be removed for the generic drug. Please keep in mind that multi-source brand name drugs may be included in the
Mandatory Generic Drug Program; again promoting the use of the most cost-effective product.